Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will MR-linac Prove A Turning Point For Radiotherapy And For Elekta?

This article was originally published in Clinica

Executive Summary

Elekta last year set off on what it hoped was a path to recovery, after reporting significantly below-par results for fiscal 2015 under the watch of the then-CEO Niklas Savander. The Swedish cancer treatment specialist unveiled a comprehensive action program and underwent a major executive reshuffle, including the appointment of a new head, Richard Hausmann, formerly chief of GE Healthcare’s MR business.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT103537

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel